Cieuta Walti, C., Cuenca Royo, A., Langohr, K., Rakic, C., López Vílchez, M. Á., Lirio, J., . . . Gambarini, A. (2022). Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study).
Citación estilo ChicagoCieuta Walti, Cécile, et al. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome. A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.
Cita MLACieuta Walti, Cécile, et al. Safety and Preliminary Efficacy On Cognitive Performance and Adaptive Functionality of Epigallocatechin Gallate (EGCG) in Children With Down Syndrome. A Randomized Phase Ib Clinical Trial (PERSEUS Study). 2022.